Maurice Hilleman
#5,274
Most Influential Person
American vaccinologist
Why Is Maurice Hilleman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maurice Ralph Hilleman was a leading American microbiologist who specialized in vaccinology and developed over 40 vaccines, an unparalleled record of productivity. According to one estimate, his vaccines save nearly eight million lives each year. Many have described him as one of the most influential vaccinologists of all time.
Maurice Hilleman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Papers
- Human hepatitis B vaccine from recombinant yeast (1984) (690)
- Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. (1967) (673)
- The Vacuolating Virus, S.V.40 (1960) (462)
- Live attenuated varicella virus vaccine. Efficacy trial in healthy children. (1984) (411)
- Propagation of Human Hepatitis A Virus in Cell Culture in Vitro (1979) (383)
- Protective efficacy of pneumococcal polysaccharide vaccines. (1977) (338)
- Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. (2002) (330)
- Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum. (1967) (259)
- Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants (1978) (240)
- Development of Tumors in Hamsters Inoculated in the Neonatal Period with Vacuolating Virus, SV40 ∗ (1962) (212)
- Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. (2000) (200)
- Adenoviruses: group name proposed for new respiratory-tract viruses. (1956) (193)
- Live, attenuated mumps-virus vaccine. (1968) (187)
- Specific Immune Adherence Assay for Human Hepatitis A Antibody. Application to Diagnostic and Epidemiologic Investigations (1975) (174)
- Purification and Characterization of Chick Embryo Interferon (1963) (174)
- Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections (2004) (168)
- Antigenic variation of influenza viruses. (1954) (158)
- Live Attenuated Mumps Virus Vaccine. 1. Vaccine Development (1966) (155)
- Contributions to Characterization and Classification of Animal Viruses (1963) (137)
- Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. (1981) (131)
- Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA). (1967) (130)
- Characterization and Classification of ECHO 28-Rhinovirus-Coryzavirus Agents (1962) (124)
- Development and evaluation of the Moraten measles virus vaccine. (1968) (121)
- Purified and inactivated human hepatitis B vaccine: progress report. (1975) (119)
- Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326 (1975) (116)
- Inducers of interferon and host resistance, V. In vitro studies. (1968) (116)
- Inducers of interferon and host resistance, IV. Double-stranded replicative form RNA (MS2-Ff-RNA) from E. coli infected with MS2 coliphage. (1967) (114)
- Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. (1975) (110)
- Vaccine against human hepatitis B. (1976) (104)
- Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. (1967) (102)
- A Specific Complement-Fixation Test for Human Hepatitis A Employing CR326 Virus Antigen. Diagnosis and Epidemiology (1975) (101)
- Pneumococcal Vaccines (1978) (101)
- Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. (2001) (100)
- Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. (2003) (94)
- New Findings in Live, Attenuated Hepatitis A Vaccine Development (1986) (92)
- Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. (1962) (91)
- Etiologic Relationship of Marmoset-Propagated CR326 Hepatitis A Virus to Hepatitis in Man (1973) (89)
- Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications. (2001) (89)
- Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. (1967) (86)
- Tests in Hamsters for Oncogenic Quality of Ordinary Viruses Including Adenovirus Type 7.∗ (1964) (81)
- An Inactivated Hepatitis A Virus Vaccine Prepared from Infected Marmoset Liver (1978) (81)
- Overview: cause and prevention in biowarfare and bioterrorism. (2002) (79)
- Studies in Human Subjects of Polyvalent Pneumococcal Vaccines (1977) (78)
- Combined live measles, mumps, and rubella virus vaccines. (1969) (76)
- Interruption of SV40 Virus Tumorigenesis Using Irradiated Homologous Tumor Antigen.∗ (1964) (76)
- Inducers of Interferon and Host Resistance VI. Antiviral Efficacy of Poly I:C in Animal Models (1969) (73)
- Progress toward a Live, Attenuated Human Hepatitis A Vaccine (1982) (66)
- Recovery of Hepatitis Agents in the Marmoset from Human Cases Occurring in Costa Rica (1973) (66)
- Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man. (1970) (66)
- Inducers of Interferon and Host Resistance VII. Antiviral Efficacy of Double-Stranded RNA of Natural Origin (1969) (65)
- Recovery of New Viruses (Coryzavirus) from Cases of Common Cold in Human Adults (1961) (64)
- EPIDEMIOLOGY OF ADENOVIRUS RESPIRATORY INFECTIONS IN MILITARY RECRUIT POPULATIONS (1957) (62)
- Clinical and Laboratory Studies of Live Cytomegalovirus Vaccine Ad-169 (1979) (62)
- Clinical and Laboratory Studies of Combined Live Measles, Mumps, and Rubella Vaccines Using the RA 27/3 Rubella Virus (1980) (60)
- Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. (1961) (58)
- Studies in Chimpanzees of Live, Attenuated Hepatitis A Vaccine Candidates (1983) (57)
- Persistence of Antibody in Human Subjects for 7 to 10 Years following Administration of Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines (1980) (56)
- Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies. (1971) (55)
- New Antigenic Variant in Far East Influenza Epidemic, 1957 (1957) (53)
- Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing. (1968) (53)
- Pneumococcal Vaccine: Dose, Revaccination, and Coadministration with Influenza Vaccine (1979) (53)
- Development and Chimpanzee Testing of a Vaccine against Human Hepatitis B (1976) (52)
- Six decades of vaccine development—a personal history (1998) (50)
- Critical appraisal of emulsified oil adjuvants applied to viral vaccines. (1966) (49)
- Factors Influencing Tumor Induction in Hamsters by Vacuolating Virus, SV40.∗ (1963) (49)
- Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. (1980) (47)
- Double-stranded RNAs (poly I:C) in the prevention of viral infections. (1970) (47)
- Yeast recombinant hepatitis B vaccine (2005) (47)
- Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. (1961) (47)
- Induction of Interferon in Human Subjects by Poly I:C (1971) (47)
- Immunological Studies on the Psittacosis-lymphogranuloma Group of Viral Agents (1945) (46)
- Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus (1981) (46)
- DNA vaccines : a new era in vaccinology (1995) (45)
- Immunologic studies of measles. (1961) (45)
- Epidemiologic investigations with respiratory disease virus RI-67. (1955) (45)
- Use of living attenuated measles-virus vaccine in early infancy. (1960) (44)
- Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. (1975) (44)
- Persistence of Pneumococcal Antibodies in Human Subjects following Vaccination (1980) (44)
- Seroepidemiologic Investigations of Human Hepatitis Caused by A, B, and a Possible Third Virus 1 (1976) (44)
- Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. (1961) (43)
- Interferon induction and utilization (1968) (43)
- Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS. (1994) (43)
- Summary of worldwide clinical experience with H-B-Vax (B, MSD). (1983) (43)
- Inactivation of hepatitis B virus by three methods: Treatment with pepsin, urea, or formalin (1983) (42)
- Live, attenuated rubella-virus vaccine. (1968) (42)
- Hyperpotentiation by Synthetic Double-Stranded RNA of Antibody Responses to Influenza Virus Vaccine in Adjuvant 65 (1969) (41)
- Efficacy of Live, Attenuated Measles-Virus Vaccine given with Human Immune Globulin. A Preliminary Report. (1961) (40)
- Newer directions in vaccine development and utilization. (1985) (39)
- Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations. (1969) (39)
- Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains. (1969) (39)
- Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines. (1978) (39)
- The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group. (1951) (38)
- Polyvalent pneumococcal polysaccharide vaccines. (1979) (38)
- Live attenuated rubella virus vaccines prepared in duck embryo cell culture. II. Clinical tests in families and in an institution. (1968) (38)
- The Induction of Interferon (1971) (38)
- Enzyme-linked immunosorbent assay for measurement of antibodies against pneumococcal polysaccharide antigens: comparison with radioimmunoassay (1979) (37)
- Rubella Vaccination in Adult Females (1969) (37)
- Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology (1999) (37)
- Comparison of Neutralization and Hemagglutination-Inhibition Techniques for Measuring Mumps Antibody (1967) (36)
- Biophysical Characterization of the RI (RI-67) Viruses.∗ (1955) (36)
- IMMUNOLOGIC, CHEMOTHERAPEUTIC AND INTERFERON APPROACHES TO CONTROL OF VIRAL DISEASE. (1965) (36)
- Haemophilus influenzae Type b Polysaccharide-Protein Conjugate Vaccine (1987) (36)
- Prevention of Acute Respiratory Illness in Recruits by Adenovirus∗ (RI-APC-ARD) Vaccine.† (1956) (36)
- Grouping and Occurrence of RI (Prototype RI-67) Viruses.∗ (1955) (35)
- Herpes simplex vaccines. (1976) (35)
- Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). (1956) (35)
- New Metabolizable Immunologic Adjuvant∗ for Human Use. I. Development and Animal Immune Response (1964) (35)
- Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. (1962) (34)
- The preparation and safety of hepatitis B vaccine. (1983) (33)
- Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. (1957) (33)
- A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS. (1998) (33)
- Studies of Acute Respiratory Illnesses Caused by Respiratory Syncytial Virus. 1. Laboratory Findings in 109 Cases (1961) (32)
- Antibody response in volunteers to Asian influenza vaccine. (1958) (32)
- Characterization of Chick Embryo Interferon Induced by a DNA Virus (1965) (32)
- Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines. (1998) (32)
- Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. (1955) (31)
- Therapeutic vaccines: Realities of today and hopes for tomorrow (2004) (30)
- Follow-Up Surveillance for Antibody in Human Subjects following Live Attenuated Measles, Mumps, and Rubella Virus Vaccines (1979) (30)
- Live Respiratory Syncytial Virus Vaccine Administered Parenterally (1978) (30)
- Live attenuated mumps virus vaccine. II. Early clinical studies. (1967) (30)
- INTERFERON IN PROSPECT AND PERSPECTIVE. (1963) (30)
- Influence of age on clinical response to HPV-77 duck rubella vaccine. (1972) (29)
- Differentiation of Virulent from Avirulent Measles Strains (1962) (29)
- Overview of the Needs and Realities for Developing New and Improved Vaccines in the 21st Century (2003) (29)
- The clinical application of adjuvant 65. (1972) (29)
- Clinical and Laboratory Studies of Live Attenuated RA 27/3 and HPV 77-DE Rubella Virus Vaccines (1980) (29)
- Suitability of the Rufiventer Marmoset as a Host Animal for Human Hepatitis A Virus (1977) (29)
- Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. (1956) (29)
- Further Investigations of Live Respiratory Syncytial Virus Vaccine Administered Parenterally (1979) (28)
- Comparative biology and pathogenesis of AIDS and hepatitis B viruses: related but different. (1994) (28)
- Overview of vaccinology with special reference to papillomavirus vaccines. (2000) (28)
- Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. (2000) (28)
- Influence of Polyamines on Induction of Interferon and Resistance to Viruses by Synthetic Polynucleotides (1969) (28)
- Epidemiologic Investigations of Rhinovirus Infections (1964) (28)
- Influence of Synthetic Double-Stranded Ribonucleic Acid, Poly I:G, on Friend Leukemia in Mice 1 (1969) (28)
- Influence of Size of Individual Homopolynucleotides on the Physical and Biological Properties of Complexed rIn:rCn (Poly I:C) (1970) (27)
- Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus. (1961) (27)
- Advances in control of viral infections by nonspecific measures and by vaccines, with special reference to live mumps and rubella virus vaccines (1966) (27)
- Hepatitis and hepatitis A vaccine: a glimpse of history. (1993) (27)
- Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. (1957) (27)
- Past, present, and future of measles, mumps, and rubella virus vaccines. (1992) (27)
- Influence of Synthetic (Poly I:C) and Viral Double-Stranded Ribonucleic Acids on Adenovirus 12 Oncogenesis in Hamsters∗ (1969) (27)
- Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS. (1992) (27)
- Additional Rhinovirus Serotypes (1964) (26)
- Critical appraisal of emulsified oil adjuvants applied to viral vaccines. (1966) (26)
- Relationship of Molecular Size of rIn:rCn (Poly I:C) to Induction of Interferon and Host Resistance (1970) (26)
- POLY I:C, AN INDUCER OF INTERFERON AND INTERFERENCE AGAINST VIRUS INFECTIONS (1972) (26)
- Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat. (1978) (26)
- Studies of Oncogenicity of Adenovirus Type 7 Viruses in Hamsters.∗ (1965) (25)
- Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial. (1969) (25)
- Influenza antibodies in the population of the USA; an epidemiological investigation. (1953) (25)
- Distribution and significance of Asian and other influenza antibodies in the human population. (1958) (25)
- Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine. (1971) (25)
- OUTBREAK OF ACUTE RESPIRATORY ILLNESS CAUSED BY RI-67 AND INFLUENZA A VIRUSES, FORT LEONARD WOOD, 1952–1953, (1955) (24)
- Influence of Synthetic Double-Stranded Ribonucleic Acid (Poly I: C) on SV40 Viral Oncogenesis and Transplant Tumor in Hamsters 1 (1970) (24)
- Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions. (1962) (24)
- Development and utilization of complement-fixation and immune adherence tests for human hepatitis A virus and antibody. (1975) (24)
- Isolation of Hepatitis A Virus in Vitro in Cell Culture Directly from Human Specimens (1981) (23)
- Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine. (1966) (23)
- Studies for safety of adjuvant 65. (1972) (23)
- Toward control of viral infections of man. (1969) (23)
- Human hepatitis B vaccine from recombinant yeast. 1984. (1992) (23)
- History, precedent, and progress in the development of mammalian cell culture systems for preparing vaccines: Safety considerations revisited (1990) (22)
- Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy. (1962) (22)
- Poly I:C/poly-L-lysine: potent inducer of interferons in primates. (1981) (22)
- Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. (1962) (21)
- Antigenic Pattern of Strains of Influenza A and B (1950) (21)
- Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU) (1965) (21)
- Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units. (1983) (21)
- Jeryl Lynn Strain Live Attenuated Mumps Virus Vaccine: Influence of Age, Virus Dose, Lot, and γGlobulin Administration on Response (1968) (21)
- Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity. (1958) (20)
- Electron microscopy of type 4 adenovirus strain R1-67. (1957) (20)
- Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle. (1961) (20)
- Marek's disease vaccine: its implications in biology and medicine. (1972) (19)
- Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza. (1953) (19)
- Line cell saga - an argument in favor of production of biologics in cancer cells. (1979) (19)
- Double-Stranded Polynucleotides as Interferon Inducers (1970) (19)
- Studies of live attenuated measles virus vaccine in man. I. Clinical aspects. (1962) (19)
- Vaccine Supply and Innovation (1987) (18)
- Vaccine against Human Hepatitis B Virus Prepared from Antigen Derived from Human Hepatoma Cells in Culture (1984) (18)
- ADENOVIRUS (RI-APC-ARD) VACCINE FOR PREVENTION OF ACUTE RESPIRATORY ILLNESS: 2. FIELD EVALUATION (1957) (18)
- Studies on lymphogranuloma venereum complement-fixing antigens; enhancement by phenol or boiling. (1946) (18)
- Prevention of SV40 Virus Tumorigenesis by Irradiated, Disrupted and Iododeoxyuridine Treated Tumor Cell Antigens.∗ (1967) (18)
- Laboratory studies on the 1950 outbreak of influenza. (1950) (17)
- Multiple Molecular Species of Interferons of Mouse and of Rabbit Origin (1966) (17)
- RESPIRATORY SYNCYTIAL VIRUS. (1963) (17)
- Vaccines made from recombinant yeast cells. (1986) (17)
- Administration of Enders' live measles virus vaccine with human immune globulin. (1962) (17)
- Further Tests in Hamsters for Oncogenic Quality of Ordinary Viruses and Mycoplasma, with Correlative Review.∗ (1965) (17)
- Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic. (1967) (17)
- Rubella vaccination in adult females. (1969) (17)
- Clinical-laboratory experiences with combined dried live measles-smallpox vaccine. (1966) (17)
- Protective efficacy of duck embryo rubella vaccines. (1969) (16)
- Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine. (1958) (16)
- Efficacy of and indications for use of adenovirus vaccine. (1958) (16)
- Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies. (1971) (16)
- Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine. (1995) (16)
- New Metabolizable Immunologic Adjuvant∗ for Human Use. 2. Short-term Animal Toxicity Tests (1964) (16)
- THE PARAINFLUENZA VIRUSES OF MAN (1962) (15)
- Scale‐up of Chick Cell Growth on Microcarriers in Fermenters for Vaccine Production (1983) (15)
- Search for Virus in Human Malignancies. 1. In vitro Studies.∗ (1962) (15)
- System for Measuring and Designating Antigenic Components of Influenza Viruses with Analyses of Recently Isolated Strains (1951) (15)
- Biophysical and biochemical properties of CR326 human hepatitis A virus. (1975) (15)
- Combined live measles-mumps virus vaccine. (1973) (15)
- Enhancement in hamsters of virus oncogenesis attending vaccination procedures. (1965) (15)
- Vaccination of adults with live attenuated mumps virus vaccine. (1967) (15)
- Recombinant vector vaccines in vaccinology. (1994) (15)
- Respiratory Tract Diseases. (1961) (15)
- Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). (1975) (15)
- DNA Vectors Precedents and Safety (1995) (15)
- Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies. (1971) (15)
- The dilemma of AIDS vaccine and therapy. Possible clues from comparative pathogenesis with measles. (1992) (14)
- Quality and safety of human hepatitis B vaccine. (1983) (14)
- Respiratory virus vaccines. 8. Field evaluation of trivalent parainfluenza virus vaccine among preschool children in families, 1967-1968. (1969) (14)
- Respiratory viruses and respiratory virus vaccines. (1963) (14)
- Whether and when an AIDS vaccine? (1995) (14)
- Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development. (1957) (14)
- Failure of Thymopoietin, Ubiquitin and Synthetic Serum Thymic Factor to Restore Immunocompetence in T-Cell Deficient Mice (1978) (14)
- Respiratory virus vaccines. VII. Field evaluation of respiratory syncytial, parainfluenza 1, 2, 3, and Mycoplasma pneumoniae vaccines, 1965 to 1966. (1967) (14)
- Clinical and Laboratory Investigations of Monovalent and Combined Meningococcal Polysaccharide Vaccines, Groups A and C (1976) (13)
- Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction. (1946) (13)
- Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination. (1969) (13)
- Attempt at Immunization by Oral Feeding of Live Rhinoviruses in Enteric-Coated Capsules (1966) (13)
- Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 and one-half years) virus vaccines. (1972) (13)
- Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. (1958) (13)
- Host-Virus Relationships in Hamsters Inoculated with SV40 Virus During the Neonatal Period.∗ (1964) (13)
- Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines. (1973) (12)
- Ten-Year Follow-Up Study for Safety of Adjuvant 65 Influenza Vaccine in Man (1973) (12)
- Viruses of special interest to the dermatologist; a review. (1950) (12)
- Studies on Induction of Virus from Adenovirus and SV40 Hamster Tumors 1. Chemical and Physical Agents.∗ (1966) (12)
- Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology. (1957) (12)
- The business of science and the science of business in the quest for an AIDS vaccine. (1999) (12)
- Development of a purified poliomyelitis virus vaccine. (1961) (12)
- Cooperation between government and industry in combating a perceived emerging pandemic. The 1976 swine influenza vaccination program. (1996) (12)
- Immunologic Relations of the Psittacosis-Lymphogranuloma Group of Viral Agents.∗ (1944) (12)
- Immunologic Responses in Hamsters to Homologous Tumor Antigens Measured in vivo and in vitro ∗ (1967) (12)
- A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. (1964) (11)
- Attempts to Interrupt Virus Tumorigenesis by Immunization Using Homologous “Bjorklund-Type” Antigen.∗ (1963) (11)
- Respiratory virus vaccines. I. Respiratory syncytial and parainfluenza virus vaccines. (1966) (11)
- Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis-lymphogranuloma venereum group. (1947) (11)
- Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration. (1968) (11)
- Double-Stranded RNA’s in Relation to Interferon Induction and Adjuvant Activity (1971) (11)
- A Field Trial of Combined Measles- Mumps-Rubella Vaccine (1973) (11)
- Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. (1962) (11)
- Respiratory virus vaccines. II. Mycoplasma pneumoniae (Eaton agent) vaccines. (1966) (11)
- Preparation and testing of duck embryo cell culture rubella vaccine. (1969) (11)
- Characterization of CR326 human hepatitis A virus, a probable enterovirus. (1975) (11)
- Cells, vaccines and the pursuit of precedent. (1968) (11)
- New metabolizable immunologic adjuvant for human use. X. Long-term serologic and clinical follow-up. (1970) (11)
- Prevention of Viral and Transplant Tumors in Hamsters Employing Killed and Fragmented Homologous Tumor Cell Vaccines∗ (1968) (10)
- Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. (1956) (10)
- Infectivity stability of live measles-virus vaccine. (1962) (10)
- NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN. (1964) (10)
- DURABLE IMMUNITY TWO YEARS AFTER ADMINISTRATION OF ENDERS'S LIVE MEASLES-VIRUS VACCINE WITH IMMUNE GLOBULIN. (1964) (10)
- Immune adherence and complement-fixation tests for human hepatitis A. Diagnostic and epidemiologic investigations. (1975) (10)
- Serologic responses to split and whole swine influenza virus vaccines in light of the next influenza pandemic. (1977) (10)
- The roles of early alert and of adjuvant in the control of Hong Kong influenza by vaccines. (1969) (9)
- Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine. (1970) (9)
- The Effect of Altering the Size of Poly C on the Toxicity and Antigenicity of Poly I:C (1972) (9)
- Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition. (1952) (9)
- Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations. (1958) (9)
- Optimization techniques: Studies in cell culture (1983) (8)
- New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65. (1967) (8)
- Personal reflections on twentieth century vaccinology. (2003) (8)
- Development of Immunity Against Hepatitis A Virus by Subclinical Infection 1 (1976) (8)
- Antigenicity of Double-Stranded Ribonucleic Acids Including Poly I:C (1972) (8)
- Immunogenic response to killed measles-virus vaccine. Studies in animals and evaluation of vaccine efficacy in an epidemic. (1962) (8)
- Infectious hepatitis (hepatitis A) research in nonhuman primates. (1977) (8)
- Complement-Fixation Reaction of Human Neoplastic Tissue with Sera From Hamsters Bearing Virus-Induced Tumors.∗ (1967) (8)
- Infection and Immunization of Cats with the Kawakami-Theilen Strain of Feline Leukemia Virus 1 (1979) (7)
- Acute respiratory illness in volunteers following intramuscular administration of live adenovirus. (1957) (7)
- Cellular Control of Interferon Production and Release After Treatment with Poly I:C Inducer (1972) (7)
- A PROTECTIVE ANTISERUM AGAINST MOUSE PNEUMONITIS VIRUS. (1943) (7)
- Acute respiratory illness caused by adenoviruses; a military problem. (1956) (7)
- Influenza B in the Spring of 1965 (1966) (7)
- CLINICAL-EPIDEMIOLOGIC FINDINGS IN CORYZAVIRUS INFECTIONS. (1963) (7)
- Improving the heat stability of vaccines: problems, needs, and approaches. (1989) (7)
- The Development of Live Attenuated Mumps Virus Vaccine in Historic Perspective and Its Role in the Evolution of Combined Measles–Mumps–Rubella (2011) (7)
- Whither immunization against viral infections? (1984) (7)
- Prevention of SV40 Virus Tumorigenesis in Newborn Hamsters by Maternal Immunization.∗ † (1967) (7)
- Hepatitis B and AIDS and the promise for their control by vaccines. (1988) (7)
- Measles, mumps and rubella virus vaccines prepared from virus produced by unit process. (1975) (6)
- THE ECHO 28-RHINOVIRUS-CORYZAVIRUS (ERC) GROUP OF VIRUSES. (1963) (6)
- Progress toward a live attenuated human hepatitis A virus vaccine. (1983) (6)
- Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. II. Development and appraisal of potency of SF-4 (shipping fever) virus vaccine. (1961) (6)
- Human cancer virus vaccines and the pursuit of the practical (1974) (6)
- A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. (1964) (6)
- In vivo and in vitro studies of serological specificity among viruses of the psittacosis-lymphogranuloma venereum group. (1952) (6)
- POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE. (1963) (6)
- Antibody Response in Man to Hong Kong Influenza Following 1967 Formula Influenza Vaccine in Adjuvant 65 (1969) (6)
- Studies on Induction of Virus from Adenovirus and SV40 Hamster Tumors 2. “Helper” Viruses.∗ (1966) (6)
- A guinea pig potency test for adenovirus vaccine. (1960) (6)
- Do family planning facilities meet the needs of the sexually active teenagers (1988) (6)
- Virus vaccines (1985) (6)
- Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis lymphogranuloma venereum group. (1947) (6)
- Historical and contemporary perspectives in vaccine developments: from the vantage of cancer. (1992) (6)
- Vaccines against hepatitis A and B (1993) (6)
- Search for Virus in Human Malignancies. 2. In vivo Studies.∗ (1962) (5)
- Rhinovirus Infection in Nursery and Kindergarten Children. New Rhinovirus Serotype 54 (1967) (5)
- Respiratory viruses and respiratory virus vaccines. (1963) (5)
- The Promise and the Reality of Viral Vaccines against Cancer (1993) (5)
- Tests for Oncogenicity of Viruses Under Conditions of Altered Host and Virus 1 (1971) (5)
- Tests in rufiventer and other marmosets of susceptibility to human hepatitis A virus. (1978) (5)
- New Metabolizable Immunologic Adjuvant for Human Use. 4. Development of Highly Purified Influenza Virus Vaccine in Adjuvant 65 (1966) (5)
- POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA. (1963) (5)
- SOME PRECLINICAL STUDIES IN ANIMAL MODELS WITH DOUBLE‐STRANDED RNA'S (1970) (5)
- The control of viral diseases, with special reference to mumps, rubella, and interferon (1968) (5)
- Search for Virus in Human Malignancies. 4. Tests of Human Neoplastic Tissues in Sex-Segregated Mice.∗ (1966) (5)
- Immunologic responses in hamsters to homologous tumor antigens measured in vivo and in vitro (1967) (5)
- New metabolizable immunologic adjuvant for human use. IX. Large-scale trials with multiple lots in different regimens. (1969) (5)
- Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients. (1958) (5)
- Present knowledge of the rhinovirus group of viruses. (1967) (5)
- Effect of Westphal Lipid A on Viral Activities in Mice and Hamsters (1962) (5)
- Present knowledge of the rhinovirus group of viruses. (1967) (5)
- Coloscopy: endoscopic examination of the colon. (1956) (5)
- PROSPECTS FOR THE ROLE OF VIRUSES IN HUMAN MALIGNANCY. (1964) (5)
- PROSPECTS FOR THE ROLE OF VIRUSES IN HUMAN MALIGNANCY. (1964) (4)
- The Frustrating Journey toward an AIDS Vaccine (2000) (4)
- Laryngocele: an unusual tumor of the neck; case report. (1954) (4)
- Status report on adenoviruses and Asian influenza. (1958) (4)
- International biological standardization in historic and contemporary perspective. (1999) (4)
- New developments with new vaccines. (1980) (4)
- Stabilized measles vaccine in a novel single-dose delivery system: a practical reality for worldwide elimination of measles. (1983) (4)
- Vaccinology in practical perspective. (1986) (4)
- CHAPTER 19 – Prospects for Vaccines against Cancer (1974) (4)
- Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine. (1966) (4)
- Combined Measles, Mumps, and Rubella Vaccines (1999) (4)
- Variations in immunogenicity of disrupted cells prepared from an adenovirus-7 hamster tumor cell line. (1971) (4)
- Development of anal ducts and glands with reference to the pathogenesis of anorectal disease. (1949) (4)
- Vaccines for the decade of the 1980s and beyond. (1982) (4)
- On Use of Urea- and Phenol-Treated Skin Test Antigens for Diagnosis of Lymphogranuloma venereum. (1947) (3)
- Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine. (1969) (3)
- A novel single-dose delivery system for vaccines. (1982) (3)
- Overview of viruses, cancer, and vaccines in concept and in reality. (1998) (3)
- Historical and contemporary perspectives in vaccine developments: from the vantage of cancer. (1992) (3)
- Clinical Laboratory Evaluation of Rubella Virus Vaccine Given to Postpartum Women Without Pregnancy Preventive (1973) (3)
- A safe high-speed blendor for processing infectious materials. (1958) (3)
- Overview of Vaccinology in Historic and Future Perspective (2003) (3)
- Demonstration of Double-Stranded Ribonucleic Acid in Concentrates of RNA Viruses (1972) (3)
- Vaccine, chemotherapy, and host resistance approaches to control of viral respiratory disease. (1966) (3)
- Overview: Past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B (2002) (3)
- Recombinant yeast hepatitis B vaccine. (1986) (3)
- Respiratory virus vaccines. VI. Serologic responses to heptavalent vaccine among young children in families. (1967) (3)
- In Vitro Safety Assessment of Double-Stranded Polynucleotides Poly I:C and Mu-9 (1971) (3)
- Cells, vaccines, and the pursuit of precedent. (1968) (3)
- Microelectrode probes for biomedical applications. (1990) (3)
- Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. (1951) (3)
- Porcine stress deaths (1992) (3)
- Lack of identity of polyoma virus and pneumonia virus of mice (PVM). (1960) (3)
- Alopecia in calves associated with milk substitute feeding (1983) (3)
- Occurrence and significance of adenovirus antibody in sera of recruit and cadre military personnel. (1958) (3)
- Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. (1951) (3)
- Immunologic response in hamsters to homologous tumor antigens measured in vivo and in vitro. (1967) (2)
- Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica. (1971) (2)
- Strategies for the achievement of prophylactic vaccination against HIV. (1996) (2)
- Search for Virus in Human Malignancies. 3. Sex Segregation and Neoplasia in ICR/Ha Mice.∗ (1963) (2)
- The science of vaccines in present and future perspective (1986) (2)
- Perspectives for testing safety of live measles vaccine. (1962) (2)
- Jeryl Lynn strain live mumps virus vaccine. (1969) (2)
- Cells, vaccines and the pursuit of precedent. (1968) (2)
- Perspectives in the control of viral diseases including cancer. (1972) (2)
- A safe high-speed blendor for processing infectious materials. (1958) (2)
- Three Decades of Hepatitis Vaccinology in Historic Perspective. A Paradigm of Successful Pursuits (2011) (2)
- Respiratory virus vaccines. IV. Heptavalent respiratory syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons. (1966) (2)
- The role of industry in the development of new biologicals. (1977) (2)
- High-resolution flow-zonal centrifuge system. (1979) (2)
- ECHO virus, type 25, in respiratory illness. Case report. (1963) (2)
- A pattern of antigen variation. (1952) (2)
- Present status of recombinant hepatitis B vaccine. (1988) (2)
- An evaluation of the surgical treatment of carcinoma of the stomach. (1956) (2)
- Conclusions: in pursuit of an AIDS virus vaccine. (1989) (2)
- The Quality of Measles Virus Vaccine (1965) (2)
- Hepatitis viruses and vaccines (1978) (2)
- Human cancer virus vaccines (1974) (2)
- New developments with new vaccines. (1980) (2)
- Preparation of Measles Antiserum in Horses (1962) (1)
- Status report on adenoviruses and Asian influenza. (1958) (1)
- Safety Assessment of Poly I: C in NZB/NZW Mice (1975) (1)
- The Evaluation of Vaccines (1985) (1)
- Viral Hepatitis and Liver Disease: Editor, A.J. Zuckerman, Alan R. Liss, Inc., New York, 1988, 1160 pp., $350.00, ISBN 0-8451-4247-X (1989) (1)
- Pneumonia and meningoencephalitis in a female adolescent. Case report. (1984) (1)
- Use of poly I-poly C in the prophylaxis and treatment of acute viral infections. (1969) (1)
- Vaccines, human experimentation, and ethics in evolutionary perspective. (1998) (1)
- Cryosurgical Treatment of Primary SV40 Viral and Adenovirus 7 Transplant Tumors in Hamsters∗ (1968) (1)
- Perspectives in Disease Prevention by Vaccines (1987) (1)
- PURSUIT OF PRACTICABLE IMMUNOGENS FOR HUMAN NEOPLASIA (1968) (1)
- What is the most important achievement in viral immunology in the last five years (1995) (1)
- Vaccination against mumps. (1968) (1)
- New Metabolizable Immunologic Adjuvant∗ for Human Use 8. Chronic Toxicity and Teratogenic Tests (1968) (1)
- Problems and potentials for human viral cancer vaccines. (1972) (1)
- The 1975 I.R.I. Achievement Award Lecture: Managing Research in the Health Sciences (1976) (1)
- Viral Enhancement and Interference Induced in Cell Culture by Hepatitis A Virus: Application to Quantitative Assays for Hepatitis A Virus (1984) (1)
- Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology. (1987) (1)
- Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells (1980) (1)
- Automated cytopathic effect (CPE) assays. (1983) (1)
- Comparative Studies of SV40 and Adenovirus Oncogenesis in Random Bred and Inbred Hamsters 1 (1971) (1)
- How does a viral infection trigger an autoimmune disease (1995) (1)
- Vaccines for the decade of the 1980s and beyond. (1982) (1)
- Detection of poliovirus I in monkey kidney cultures inoculated with overwhelming dose of adenovirus 4. (1958) (1)
- The polysaccharide / protein conjugate, process for its preparation and its use in a vaccine (1984) (0)
- The role of industry in the development of new biologicals. (1977) (0)
- Use of poly I-poly C in the prophylaxis and treatment of acute viral infections. (1969) (0)
- Invited Discussions Double-Stranded Polynucleotides as Interferon Inducers (0)
- IXth International Congress of Infectious and Parasitic Diseases Munich, July 20–26, 1986 (2005) (0)
- Is immunization with naked DNA the most important factor in the development of vaccines (1995) (0)
- Mechanical apparatus for washing tissue cultures in tubes. (1955) (0)
- Discussion. Mycoplasma from human respiratory and urogenital tract. (1967) (0)
- Prophylaxe intrauteriner Virusinfektion (1970) (0)
- Studies of immunization with three types of combined viral vaccines (1971) (0)
- Two-team abdomino-perineal operation for carcinoma of rectum and rectosigmoid. (1947) (0)
- An automatic pipette for preparing serial dilutions. (1952) (0)
- Preparation and Research on Meningococcal Vaccines (1972) (0)
- Fritz will be remembered, for he was a servant to mankind and the world is a better place, because he was here. On this last fallen leaf, we inscribe our final tribute to Fritz, 'Farewell, good Friend; well done!' (1992) (0)
- Present status of recombinant hepatitis B vaccine. (1988) (0)
- The control of viral respiratory illnesses of man. (1962) (0)
- The Newer Live Virus Vaccines (2009) (0)
- Long-Term Follow-up for Immunity After Monovalent or Combined Live Measles, Mumps, and Rubella Virus Vaccines (1975) (0)
- Vaccine, chemotherapy, and host resistance approaches to control of viral respiratory disease. (1966) (0)
- Prof. Dr. F. Deinhardt — 60 years (1986) (0)
- Subject Index Vol. 45, 2002 (2003) (0)
- Regularly scheduled versus as-needed use of inhaled beta agonists in the treatment of asthma. (1992) (0)
- What are the major goals of research in viral immunology (1995) (0)
- Lactose absorption, milkconsumption, andfasting blood glucose concentrations inwomenwithidiopathic osteoporosis (1986) (0)
- Discussion. Mycoplasma from human respiratory and urogenital tract. (1967) (0)
- A review of DNA vaccines (2007) (0)
- A tribute to Professor Friedrich W. Deinhardt, scientist and statesman, 1926–1992 (1993) (0)
- Hepatitis B can teach about how to approach the development of a vaccine against AIDS (1996) (0)
- Toward prophylaxis of prenatal infection by viruses. (1969) (0)
- [Research of infectious hepatitis (hepatitis A) in non-human primates]. (1976) (0)
- Toward Prophylaxis of Prenatal Infection by Viruses (1969) (0)
- DISCUSSION (1967) (0)
- A device for storage and dispensing of vaccines and method of loading of the device (1976) (0)
- Vaccination against mumps. (1968) (0)
- Immunologic Attack on Neoplasia (1966) (0)
- Human papillomavirus vaccination workshop, Helsinki 10.01.2000: Structured discussion (2000) (0)
- Mumps vaccination. (1970) (0)
- A simple tissue washer. (1951) (0)
- On the oncogenicity of ordinary viruses (2005) (0)
- ON THE ONCOGENICITY OF ORDINARY VIRUSES. (1965) (0)
- Preface (1995) (0)
- [Advances and new approach in the control of virus diseases in man]. (1970) (0)
- Conclusions: in pursuit of an AIDS virus vaccine. (1989) (0)
- A process for increasing the activity of a vaccine. (1969) (0)
- Viral vaccines in historical perspective. (1995) (0)
- New Hepatitis A and B Vaccines: Summary of a Specialty Session (1994) (0)
- A simple tissue washer. (1951) (0)
- A tribute to Dr. Friedrich W. Deinhardt M.D. 1926-1992. (1993) (0)
- Respiratory Tract Diseases (1961) (0)
- Visualization of bacterial polysaccharides by scanning transmission electron microscopy. (1983) (0)
- DISCUSSION (1971) (0)
- A pattern of antigen variation. (1952) (0)
- The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum. (1946) (0)
- The control of viral respiratory illnesses of man. (1962) (0)
- Vaccinology in practical perspective. (1986) (0)
- Contents Vol. 45, 2002 (2003) (0)
- Part II. Mechanism of DNA Uptake and Antigen Presentation: Fate and Function of Foreign Nucleic Acids Use of Plasmid DNA for Direct Gene Transfer and Immunization. (1995) (0)
- Letter from Maurice R. Hilleman to Paul Berg (1973) (0)
- New immunologic adjuvant for human use. II. Short-term animal toxicity tests (1964) (0)
- Failure of Shier's Chemical Vaccine to Protect BALB/c Mice Against Transplant and Chemically Induced Tumors 1 (1974) (0)
This paper list is powered by the following services:
Other Resources About Maurice Hilleman
What Schools Are Affiliated With Maurice Hilleman?
Maurice Hilleman is affiliated with the following schools:
